Prospera Financial Services’s Ascendis Pharma A/S ASND Stock Holding History

Prospera Financial Services’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,993	Closed	-$351K	–	1670
2022 Q1	$351K	Buy	2,993 +1,030	+52%	+$119K	0.01%	702
2021 Q4	$264K	Sell	1,963 -856	-30%	-$127K	0.01%	743
2021 Q3	$449K	Buy	2,819 +452	+19%	+$61.9K	0.02%	563
2021 Q2	$311K	Buy	2,367 +85	+4%	+$11.3K	0.02%	644
2021 Q1	$294K	Buy	2,282 +378	+20%	+$57.4K	0.02%	623
2020 Q4	$318K	Sell	1,904 -599	-24%	-$99.1K	0.02%	524
2020 Q3	$386K	Sell	2,503 -87	-3%	-$12.5K	0.15%	126
2020 Q2	$383K	Sell	2,590 -165	-6%	-$22.7K	0.03%	395
2020 Q1	$310K	Sell	2,755 -527	-16%	-$68.5K	0.03%	385
2019 Q4	$457K	Buy	+3,282	New	+$365K	0.04%	396

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Prospera Financial Services's ASND Position: Q2 2022 in Review

Prospera Financial Services sold out of Ascendis Pharma A/S (ASND) in Q2 2022, closing a stake of 2,993 shares — an estimated $351K sold.

Prospera Financial Services first reported a position in ASND in Q4 2019 and held it in 10 quarters. The position peaked at $457K in Q4 2019. 168 funds tracked by Wall St. Rank hold ASND as of Q2 2022.

Prospera Financial Services reported no remaining Ascendis Pharma A/S position as of Q2 2022 after selling out during the quarter.
Prospera Financial Services sold 2,993 Ascendis Pharma A/S shares in Q2 2022, an estimated $351K.
Prospera Financial Services first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 10 quarters.
Prospera Financial Services's Ascendis Pharma A/S position peaked at $457K in Q4 2019.
168 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.